Revista de gastroenterologia de Mexico (English)最新文献

{"title":"Acute small bowel obstruction caused by a hemobezoar in a peptic ulcer case","authors":"E.A. Montemayor-Garza , L. Santoyo-Fexas , M.I. Wah-Suárez , L.A. González-Torres , R.A. López-Pérez , S. Ramírez-Peña","doi":"10.1016/j.rgmxen.2024.09.006","DOIUrl":"10.1016/j.rgmxen.2024.09.006","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 151-153"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143912313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The role of conservative treatment in esophageal perforation caused by the ingestion of a blister pack: A case report and literature review","authors":"J.P. Pérez-Macías , M.E. Ramírez-Solís , A.Y. Ortega-Caballero , A.I. Hernández-Guerrero , E.F. Marquez-Bornio","doi":"10.1016/j.rgmxen.2024.11.001","DOIUrl":"10.1016/j.rgmxen.2024.11.001","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 148-151"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142775270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Noncardiac chest pain beyond the esophagus: Hiatal hernia type III (mixed)","authors":"C.A. Bautista-Mondragón , J.E. Aquino-Matus , M. Figueroa-Palafox , C. Culebro-García , L.R. Valdovinos-García","doi":"10.1016/j.rgmxen.2024.07.005","DOIUrl":"10.1016/j.rgmxen.2024.07.005","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 137-138"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical description of adults with eosinophilic esophagitis treated at a Chilean university center","authors":"C. von Muhlenbrock ,&nbsp;P. Núñez ,&nbsp;R. Quera ,&nbsp;J. Venegas ,&nbsp;N. Pacheco ,&nbsp;K. Herrera ,&nbsp;F. Castro","doi":"10.1016/j.rgmxen.2024.04.010","DOIUrl":"10.1016/j.rgmxen.2024.04.010","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disease that affects the esophagus. Its epidemiology in Chile and Latin America is unknown due to the absence of population studies. Our aim was to describe the clinical, endoscopic, and histologic characteristics of adult patients diagnosed with EoE, as well as their treatment response.</div></div><div><h3>Material and methods</h3><div>A descriptive prospective study was conducted on a cohort of patients ≥ 18 years of age with an eosinophil count greater than 15 eosinophils/high power field.</div></div><div><h3>Results</h3><div>A total of 62 patients were included, 75.8% of whom were men. Mean patient age was 38 years, mean age at diagnosis was 34 years, and diagnosis was made later in men. Sixty-five percent had a concomitant immunoallergic disease, and allergic rhinitis was the most frequent. Dysphagia was the most frequent referral, with a predominance of men. Women presented more often with food allergies and peripheral eosinophilia. The most frequent endoscopic finding was edema, followed by rings, with a mean eosinophilic esophagitis endoscopic reference score (EREFS) of 3.5 and a mean eosinophil count in biopsies of 37.5 eosinophils/high power field. Men presented with a higher EREFS and eosinophil count at diagnosis. All patients received treatment and the most frequent was with proton pump inhibitors, followed by combination treatment with corticosteroids. Endoscopic (partial/total) and histologic response rates were 93.5 and 77%, respectively.</div></div><div><h3>Conclusion</h3><div>We found characteristics in our cohort similar to those described in international groups. Women presented with greater autoimmune comorbidity, peripheral eosinophilia, and food allergies, but had a lower eosinophil count and endoscopic score. We found no differences between the different therapeutic regimens.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 8-14"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tradition and advancement: 90 years of excellence of the Asociación Mexicana de Gastroenterología","authors":"J.M. Remes-Troche","doi":"10.1016/j.rgmxen.2025.01.001","DOIUrl":"10.1016/j.rgmxen.2025.01.001","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 1-3"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment of small intestinal bacterial overgrowth in Chilean patients with irritable bowel syndrome: A prospective and comparative study","authors":"C. von Muhlenbrock ,&nbsp;G. Landskron ,&nbsp;A.M. Madrid","doi":"10.1016/j.rgmxen.2024.08.003","DOIUrl":"10.1016/j.rgmxen.2024.08.003","url":null,"abstract":"<div><h3>Introduction and aim</h3><div>Patients with disorders of the gut-brain axis, such as irritable bowel syndrome (IBS), often exhibit small intestinal bacterial overgrowth (SIBO). Its treatment includes rifaximin (RF), ciprofloxacin (CF), neomycin, sulfamethoxazole-trimethoprim, and metronidazole (MZ). RF is a non-absorbable antibiotic, postulated to have fewer adverse effects. Our aim was to assess symptomatic response and SIBO eradication in patients with IBS, using three antibiotic regimens.</div></div><div><h3>Methods</h3><div>A prospective, randomized, double-blind study was conducted on IBS patients over 18 years of age, utilizing the Rome IV questionnaire and lactulose breath test. Those diagnosed with SIBO were randomly assigned to receive antibiotic treatment. Group A was treated with RF, group B with CF, and group C with MZ, each for 10 days. Treatment response was evaluated based on the SIBO eradication rate 15 days after completing therapy, utilizing hydrogen and methane breath tests with lactulose. Self-reported symptoms were recorded on a 10-point Likert scale before, during, and after treatment.</div></div><div><h3>Results</h3><div>Ninety-seven patients with IBS and SIBO were included, 81% of whom completed treatment. Fifty-nine percent of the patients treated with RF achieved SIBO eradication, compared with 53% and 79% of those treated with CR and MZ, respectively. Metronidazole reduced more methane levels, compared with the other groups. However, the greatest reduction in abdominal pain and bloating was observed in the RF group, with a lower percentage of adverse events.</div></div><div><h3>Conclusions</h3><div>Patients with IBS and SIBO benefit from antibiotic therapy. MZ exhibited the best SIBO eradication rate, but RF demonstrated greater symptomatic improvement and a lower rate of adverse effects.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 54-62"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143912308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transitioning from NAFLD to MAFLD to MASLD in the Mexican population","authors":"B.A. Priego-Parra ,&nbsp;R. Bernal-Reyes ,&nbsp;M.E. Icaza-Chávez ,&nbsp;S.E. Martínez-Vázquez ,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmxen.2024.09.007","DOIUrl":"10.1016/j.rgmxen.2024.09.007","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 153-156"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143912314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024","authors":"J.M. Remes-Troche ,&nbsp;E. Coss-Adame ,&nbsp;M. Schmulson ,&nbsp;K.R. García-Zermeño ,&nbsp;M. Amieva-Balmori ,&nbsp;R. Carmona-Sánchez ,&nbsp;O. Gómez-Escudero ,&nbsp;P.C. Gómez-Castaños ,&nbsp;M.E. Icaza-Chávez ,&nbsp;A. López-Colombo ,&nbsp;E.C. Morel-Cerda ,&nbsp;M.Á. Valdovinos-Díaz ,&nbsp;L.R. Valdovinos-García ,&nbsp;A.S. Villar-Chávez","doi":"10.1016/j.rgmxen.2024.10.009","DOIUrl":"10.1016/j.rgmxen.2024.10.009","url":null,"abstract":"<div><h3>Introduction</h3><div>The aim of this position statement is to provide health professionals with an updated and evidence-based guideline for the pharmacologic management of irritable bowel syndrome (IBS) in Mexico.</div></div><div><h3>Material and methods</h3><div>A literature review was conducted that included relevant guidelines and studies, up to the date of its publication. The mechanism of action, specific indications in IBS, safety profile, and availability of each therapeutic class were evaluated. The recommendations were developed by 14 experts, considering the clinical reality of IBS patients in Mexico.</div></div><div><h3>Results</h3><div>Specific recommendations were issued for each class. Antispasmodics (alone or combined) are used as first-line therapy for pain management, whereas antidiarrheals, such as loperamide, are used for reducing diarrhea in diarrhea-predominant IBS (IBS-D) and laxatives are used for constipation in constipation-predominant IBS (IBS-C). 5-HT4 agonists (prucalopride and mosapride) are recommended in IBS-C and 5-HT3 antagonists (ondansetron) are recommended in IBS-D. Linaclotide is the only secretagogue available in Mexico and is used in IBS-C. Rifaximin-alpha stands out for its efficacy in a subgroup of patients with IBS-D or mixed IBS. Probiotics are conditionally recommended as adjuvant therapy due to heterogeneous evidence. Neuromodulators (tricyclic antidepressants, selective serotonin reuptake inhibitors, etc.) are recommended as second-line treatment for pain management. Mesalazine can be used in IBS-D, but the corresponding evidence is weak.</div></div><div><h3>Conclusion</h3><div>Overall, these recommendations provide a solid framework for personalizing treatment, based on the clinical characteristics of the Mexican patient with IBS.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"90 1","pages":"Pages 77-110"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143911603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Clinical utility of the solid meal test during high-resolution esophageal manometry. A study in a Latin American population","authors":"K.R. García-Zermeño ,&nbsp;J. Argüero ,&nbsp;M. Amieva-Balmori ,&nbsp;O. Rodríguez-Aguilera ,&nbsp;A. Martínez-Conejo ,&nbsp;M. Marcolongo ,&nbsp;J.M. Remes-Troche","doi":"10.1016/j.rgmxen.2023.05.009","DOIUrl":"10.1016/j.rgmxen.2023.05.009","url":null,"abstract":"<div><h3>Introduction and aims</h3><div>The solid test meal (STM) is a challenge test that is done during esophageal manometry and appears to increase the diagnostic yield of the study. The aim of our analysis was to establish the normal values for STM and evaluate its clinical utility in a group of Latin American patients with esophageal disorders versus healthy controls.</div></div><div><h3>Material and methods</h3><div>A cross-sectional study was conducted on a group of healthy controls and consecutive patients that underwent high-resolution esophageal manometry, in which STM was done at the final part of the study and consisted of asking the subjects to eat 200 g of precooked rice. The results were compared during the conventional protocol and the STM.</div></div><div><h3>Results</h3><div>Twenty-five controls and 93 patients were evaluated. The majority of the controls (92%) completed the test in under 8 min. The STM changed the manometric diagnosis in 38% of the cases. The STM diagnosed 21% more major motor disorders than the conventional protocol; it doubled the cases of esophageal spasm and quadrupled the cases of jackhammer esophagus, whereas it demonstrated normal esophageal peristalsis in 43% of the cases with a previous diagnosis of ineffective esophageal motility.</div></div><div><h3>Conclusions</h3><div>Our study confirms the fact that complementary STM during esophageal manometry adds information and enables a more physiologic assessment of esophageal motor function to be made, compared with liquid swallows, in patients with esophageal motor disorders.</div></div>","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 4","pages":"Pages 467-473"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9758275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comments on the article «Metabolic disorders across the body mass index spectrum in a Colombian population with nonalcoholic fatty liver disease»","authors":"P.G. Hernández-Almonacid ,&nbsp;X. Marin-Quintero","doi":"10.1016/j.rgmxen.2024.08.001","DOIUrl":"10.1016/j.rgmxen.2024.08.001","url":null,"abstract":"","PeriodicalId":74705,"journal":{"name":"Revista de gastroenterologia de Mexico (English)","volume":"89 4","pages":"Pages 558-559"},"PeriodicalIF":0.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142514368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}